.32]) of the gene SLC25A3 on subset C of the GTEx data. Panel B shows sashimi plots of the RNA-seq data from the colon and heart samples from individual 11I78. The highlighted area corresponds to the genomic coordinates of the exons shown in Panel A. These mutually exclusive exons were initially described in an independent study SR1 that also used RNA-seq data but different bioinformatic methods. As shown in these two panels as well as in figure 1A from the previous study SR1 , this splicing event is regulated differently in heart as compared to other tissues.
Figure S3: Panel A shows a heatmap representation of relative spliced-in coefficients (RSICs) for the exonic regions (E031-E037; all with q-values < 0.1 and tissue scores > 1.5) corresponding to two mutually exclusive alternative exons of the gene MEF2C on subset B of the GTEx data. Panel B shows sashimi plots of the RNA-seq data from the skeletal muscle and thyroid samples from individual 11DXX. The highlighted area corresponds to the genomic coordinates of the exons shown in Panel A. This splicing event was initially described for mouse tissues in an independent study SR2 using RT-PCR. This splicing event is regulated differently in skeletal muscle as compared to other tissues. Figure 2C from the original study SR2 shows the exact same pattern for mouse tissues, which demonstrates that it is a conserved event.
Figure S4: Panel A shows a heatmap representation of relative exon usage coefficients (REUCs) for the 8 exonic regions of the gene ANK3 with the highest tissue scores (all with q-values < 0.1 and tissue scores > 2.19). Panel B shows sashimi plots of the RNAseq data from the skeletal muscle and tibial nerve samples from individual 11DXX. Skeletal muscle and tibial nerve initiate transcription from different transcription start sites. Panel C shows sashimi plots (using the same samples as panel B) highlighting an exon-skipping event (exonic region E067) that is differentially regulated between skeletal muscle and tibial nerve. These three panels show that ANK3 transcript isoforms expressed in skeletal muscle are very different to the ones expressed in the rest of the tissues. The expression of skeletal muscle-specific isoforms of ANK3 has been previously described in rats using northern blots SR3 . Our analysis of human RNAseq data substantiates this finding (63 out of the 109 exonic regions of this gene were detected as tissue-dependent), and further indicates that skeletal-muscle undergoes an isoform switch involving both alternative start sites and alternative splicing.
Figure S5: Panel A shows a heatmap representation of the relative spliced-in coefficients (RSICs) for the exonic region E006 (q-values < 0.1 and tissue score > 1.21) of the gene SGCE. Panel B shows sashimi plots of the RNA-seq data from the hippocampus and cerebellum samples from individual 12ZZX. The highlighted region corresponds to the genomic coordinates of the exon E006. As shown in these two panels, this cassette event is differentially regulated across brain regions. This pattern of tissue-dependent usage was also observed in another study using qPCR SR4 : Figure 2 of that study also shows that exon E006, labelled there as "11b", is frequently included in cerebellum as compared to the rest of the brain regions. Figure S6 : Panel A shows a heatmap representation of the relative exon usage coefficients (REUCs) for the exonic regions E056 (q-values < 0.1 and tissue score = 1.01) and E061 (q-values < 0.1 and tissue score = 1.32) of the gene MYO1C. Panel B shows relative spliced-in coefficients (RSICs) for the same exonic regions. Exon E056 is alternatively spliced, while the usage of E061 depends on the usage of a transcription start site. Panel C shows sashimi plots of the RNA-seq data from the heart and colon samples from individual ZF29. The highlighted regions corresponds to the genomic coordinates of exons E056 and E061. These three panels show that an alternative first exon event is differentially regulated across tissues. While heart uses exon E061 and splices out exon E056, the rest of the tissues use more frequently a TSS in E056. This same tissue-dependent event has been previously described in mouse tissues using quantitative real-time PCR SR5 : in that study, exon E056 was labelled "Exon -1" (coding for the peptide MRYRA* both in human and mouse) and exon E061 was labelled as "Exon -2" (coding for the peptide MALQVE* both in human and mouse). Interestingly, while this splicing event is conserved between human and mouse, the patterns of exon inclusion were different between corresponding tissues of the two species (particularly for heart tissue). This observation is consistent with human tissue qPCR data (Maly and Hofmann, 2016, unpublished, personal communication).
Figure S7: Panel A shows a heatmap representation of the relative exon usage coefficients (REUCs) for the exonic regions E045 (q-values < 0.1 and tissue score = 1.15) and E046 (q-values < 0.1 and tissue score = 1.18) of the gene KSR1. Panel B shows a sashimi plot of the RNA-seq data from the cerebellum and caudate samples from individual 13JVG. The highlighted regions corresponds to the genomic coordinates of the exons E045 and E046. Our data shows that an alternative splicing event is differentially regulated across brain cell types. The resulting exon inclusion differences are very prominent when comparing cerebellum with caudate samples. This same pattern of tissue-dependent usage has been previously described in mouse using immunoprecipitation assays and immunohistochemical stainings SR6 . Thus, our data shows that the regulation of this splicing event is conserved between human and mouse. Figure S8 : Panel A shows a heatmap representation of the relative spliced-in coefficients (RSICs) for the exonic regions E039 (q-values < 0.1 and tissue score = 1.69) of the gene ATP11B. Panel B shows a sashimi plot of the RNA-seq data from the stomach and heart samples from individual XBED. The highlighted region corresponds to the genomic coordinates of the exonic region E039. Our data shows that an alternative splicing event is regulated in a tissue-specific manner. The inclusion of this exon is elevated in heart tissue as compared to the rest of the tissues. The same pattern of tissue-dependent usage has been previously described using microarray data and RT-PCR SR7 . Figure 5 of that study also shows elevated exon inclusion of heart tissue as compared stomach tissue. Figure S9 : Panel A shows a heatmap representation of the relative spliced-in coefficients (RSICs) for two exonic regions, E014 and E015 (q-values < 0.1 and tissue scores > 1.7) of the gene TPD52. Panel B shows a sashimi plot of the RNA-seq data from the stomach and heart samples from individual XBED. The highlighted region corresponds to the genomic coordinates of the exonic regions E014 and E015. Our data shows that these two exonic regions are regulated in a tissue-specific manner. The inclusion of these exons is elevated in heart tissue as compared to the rest of the tissues. The same pattern of tissue-dependent usage has been previously described using microarray data and RT-PCR SR7 . Figure 5 of that study also shows elevated exon inclusion of heart tissue as compared stomach tissue.
Figure S10: Panel A shows a heatmap representation of the relative spliced-in coefficients (RSICs) for exonic regions E021 (q-values < 0.1 and tissue score = 2.59) of the gene ATP5C1. Panel B shows a sashimi plot of the RNA-seq data from the esophagous and heart samples from individual 11DXX. The highlighted region corresponds to the genomic coordinates of the exonic region E021. Our data shows strong tissue-dependent inclusion patterns for this exonic region. These differences are particularly pronounced when comparing skeletal muscle with esophagous, thyroid, skin and blood. Using RT-PCR, previous studies have also reported that skeletal muscle excludes this exon from its transcripts SR8 .
Figure S11: Panels A and C show heatmap representations of the relative spliced-in coefficients (RSICs) for exonic regions E008 and E009 of the gene NDUFV3 for two subsets of the GTEx data (q-values < 0.1, tissue scores for subset C > 2.02 and tissue scores for subset B > 0.9). Panels B and D show sashimi plots of the RNA-seq data from individuals 11DXZ (panel B) and 11DXX (panel D). The highlighted regions correspond to the genomic coordinates of the exonic regions E008 and E009. A previous study SR9 used mass spectromety to analyze splicing patterns of this exon in murine and bovine tissues. That study found that while heart and skeletal muscle frequently splice out this exon, brain, liver and lung splice in this exon more frequently. Our analysis of human tissues confirms these findigs, suggesting that this tissue-depenent pattern is also conserved in humans. Table S6 : Genes with TDEU that could be explained by alternative splicing. Each column shows data for a subset of the GTEx data. The first row shows the number of genes with tissue-dependent usage in at least one exonic region. The second row shows the subset of genes from the first row in which all the exonic regions that are used in a tissue-dependent manner have evidence of being alternatively spliced (normalized mean across samples of exon-skipping reads larger than 1). The third row shows the same quantity as the second row but expressed in percentage of genes. Table S7 : Overlap between genes with differential transcriptional start sites usage and genes with differential exon usage. Each row shows data for one subset of tissues. The first column contains the cell-types available from the FANTOM consortium for each subset of the GTEx data. The second column shows the number of genes that were tested for differential transcription start site (dTSS) usage. The third column shows the number of genes that were tested for dTSS usage that had tissue-dependent exon usage (TDEU). The fourth column shows the number of genes with dTSS usage at a FDR of 10%. The fifth column shows the number of genes with dTSS usage that were also detected to have TDEU. The sixth column shows the percentage of genes with dTSS that were also detected to have TDEU. The seventh column shows odds ratios and the eighth column shows p-values from Fisher's exact tests. Table S8 : Classification of exonic regions according to their usage across tissues and to transcript isoform annotations. The first column indicates the GTEx subset. The second column indicates exonic region classifications according to whether (a) they were detected to be differentially used and had a mean larger than ten of normalized reads supporting their alternative splicing [DEU (AS)], (b) they were differentially used and had a mean smaller than 1 of normalized read supporting their alternative splicing [DEU (NAS)], or (c) they were part of the background matched for expression strength and width [background] . The third column shows the exonic region classes according to transcript isoform annotations. The fourth column shows the number of exonic regions in each exon class. The fifth column shows, for each usage category on each data subset, the percentage exonic regions in each genomic class.
